Emerging standards in tumours with rare genetic drivers
Emerging standards in tumours with rare genetic
New data on PD-L1 inhibitor activity and determinants of outcomes in immunotherapy-treated patients
New data on PD-L1 inhibitor activity and determi
Preface – WCLC 2018
Preface – WCLC 2018 Vera Hirsh, MD Departmen
